LF-0315

N/A

Report date: 2024/04/18 16:34:31
NME

Base Information

Drug NameLF-0315
Drug Alias NameLF0315LF-0315
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutaminase kidney isoform, mitochondrial modulators
TargetsGlutaminase kidney isoform, mitochondrial
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuxi Hillhouse biomedicine Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWuxi Hillhouse biomedicine Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A